Who are in the management team of Sarepta Therapeutics, Inc.?

Jun 22 2025 10:14 PM IST
share
Share Via
As of March 2022, the management team of Sarepta Therapeutics, Inc. includes Dr. M. Kathleen Behrens (Independent Chairwoman), Mr. Douglas Ingram (President and CEO), and several Independent Directors: Mr. Richard Barry, Dr. Mary Gray, Dr. John Martin, Dr. Claude Nicaise, and Dr. Hans Wigzell. They are responsible for guiding the company's strategic direction.
As of March 2022, the management team of Sarepta Therapeutics, Inc. includes the following individuals:

- Dr. M. Kathleen Behrens, who serves as the Independent Chairwoman of the Board.
- Mr. Douglas Ingram, who is the President, Chief Executive Officer, and Director.
- The Board of Directors also includes Independent Directors: Mr. Richard Barry, Dr. Mary Gray, Dr. John Martin, Dr. Claude Nicaise, and Dr. Hans Wigzell.

This team plays a crucial role in guiding the strategic direction of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News